Section Arrow
EW.NYSE
- Edwards Lifesciences Corp
Quotes are at least 15-min delayed:2025/08/26 22:22 EDT
Regular Hours
Last
 81.27
+0.41 (+0.51%)
Day High 
81.315 
Prev. Close
80.86 
1-M High
82.255 
Volume 
4.96M 
Bid
80.85
Ask
81.84
Day Low
80.51 
Open
80.86 
1-M Low
76.07 
Market Cap 
47.47B 
Currency USD 
P/E 33.83 
%Yield -- 
10-SMA 79.35 
20-SMA 79.31 
50-SMA 77.7 
52-W High 83 
52-W Low 64.005 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
6.96/2.74
Enterprise Value
48.15B
Balance Sheet
Book Value Per Share
17.96
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
5.44B
Operating Revenue Per Share
9.91
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4303-0.0596-12.17%-- 
PTHLPheton Holdings Ltd0.6689+0.1033+18.26%-- 
MDTMedtronic plc92.18+0.14+0.15%25.5PE
ABTAbbott Laboratories131.59-0.28-0.21%16.55PE
BFLYButterfly Network1.59+0.04+2.58%-- 
Quotes are at least 15-min delayed:2025/08/26 22:22 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.